Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
The purpose of this study was to determine whether a diuretic effect may be detectable in patients treated with eplerenone, a mineralocorticoid receptor antagonist, as compared with placebo during the first month of EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival study) (n = 6,080) and whether this was associated with eplerenone's beneficial effects on cardiovascular outcomes.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of the American College of Cardiology |
Vol/bind | 58 |
Udgave nummer | 19 |
Sider (fra-til) | 1958-66 |
Antal sider | 9 |
ISSN | 0735-1097 |
DOI | |
Status | Udgivet - 2011 |
ID: 40157341